Home > Compound List > Product Information
Pancuronium_Molecular_structure_CAS_15500-66-0)
Click picture or here to close

Pancuronium

Catalog No. DB01337 Name DrugBank
CAS Number 15500-66-0 Website http://www.ualberta.ca/
M. F. C35H60N2O4++ Telephone (780) 492-3111
M. W. 572.8619 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1169

SYNONYMS

IUPAC name
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium
IUPAC Traditional name
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium
Brand Name
Pavulon
Mioblock
Synonyms
Pancuronium bromide
Bromure de pancuronium [inn-french]
Bromuro de pancuronio [inn-spanish]
Pancuronium dibromide

DATABASE IDS

CAS Number 15500-66-0
PubChem SID 46506118
PubChem CID 441289

PROPERTIES

Solubility 500 mg/mL [MERCK INDEX (1996)]

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than curare but has less effect on the circulatory system and on histamine release.
Indication Used as a muscle relaxant during anesthesia and surgical procedures.
Pharmacology Pancuronium is a typical non-depolarising curare-mimetic muscle relaxant. It acts as a competitive acetylcholine antagonist on neuromuscular junctions, displacing acetylcholine (hence competitive) from its post-synaptic nicotinic acetylcholine receptors. It is, unlike suxamethonium, a non-depolarising agent, which means, that it causes no spontaneous depolarisations upon association with the nicotinic receptor in neuromuscular junction, thus producing no muscle fasciculations upon administration. Pancuronium has no hormonal activity. It exerts slight vagolytic activity (i.e. diminishing activity of the vagus nerve) and no ganglioplegic (i.e., blocking ganglions) activity.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic.
Half Life 1.5 to 2.7 hours.
Protein Binding 77 to 91%
Distribution * 241 to 280 mL/kg
Clearance * Plasma cl=1.1–1.9 mL/minute/kg
External Links
Wikipedia

REFERENCES